Published in Hum Pathol on March 01, 2004
Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol (2009) 1.71
Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology (2007) 1.21
Sex hormones, aging, and Alzheimer's disease. Front Biosci (Elite Ed) (2012) 1.06
Oestrogen receptor alpha localisation in the prefrontal cortex of three mammalian species. J Neuroendocrinol (2008) 1.04
HIV+ men and women show different performance patterns on procedural learning tasks. J Clin Exp Neuropsychol (2010) 0.87
Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimer's disease: relationship to Mini-Mental State Examination scores. Curr Alzheimer Res (2008) 0.87
Estrogen receptor β activation is antinociceptive in a model of visceral pain in the rat. J Pain (2012) 0.85
Transcriptome meta-analysis reveals a central role for sex steroids in the degeneration of hippocampal neurons in Alzheimer's disease. BMC Syst Biol (2013) 0.81
Cerebral Abeta amyloidosis and postmenopausal hormone deficiency: roles in the genesis of Alzheimer's disease. Hum Pathol (2004) 0.75
Intra- and interspecific variation in primate gene expression patterns. Science (2002) 7.92
A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry (2007) 7.23
GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron (2007) 6.88
Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med (2013) 5.38
Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol (2002) 3.53
Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age. J Cell Sci (2007) 2.51
SRPX2 mutations in disorders of language cortex and cognition. Hum Mol Genet (2006) 2.34
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging (2010) 2.32
Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain (2003) 2.20
Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA (2008) 2.07
Hypocretin (orexin) loss in Parkinson's disease. Brain (2007) 1.98
A sex difference in the hypothalamic uncinate nucleus: relationship to gender identity. Brain (2008) 1.85
Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann Neurol (2004) 1.83
Living by the clock: the circadian pacemaker in older people. Ageing Res Rev (2005) 1.73
Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia (2006) 1.72
Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J Neurochem (2005) 1.67
Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem (2005) 1.64
Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue. BMC Mol Biol (2008) 1.62
Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain (2005) 1.58
Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol (2006) 1.56
Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol Med (2013) 1.54
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol (2002) 1.54
Age-associated difference in circadian sleep-wake and rest-activity rhythms. Physiol Behav (2002) 1.53
P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci (2007) 1.51
Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Med (2007) 1.46
Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia (2003) 1.39
Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study. Brain Pathol (2007) 1.36
Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain (2010) 1.35
Skin deep: enhanced sleep depth by cutaneous temperature manipulation. Brain (2008) 1.34
Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol (2008) 1.32
The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology (2004) 1.32
Roles of autophagy and mTOR signaling in neuronal differentiation of mouse neuroblastoma cells. Cell Signal (2008) 1.31
Sorl1 as an Alzheimer's disease predisposition gene? Neurodegener Dis (2007) 1.31
Sex differences in the brain, behavior, and neuropsychiatric disorders. Neuroscientist (2010) 1.26
Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets (2006) 1.24
Pain processing in dementia and its relation to neuropathology. Lancet Neurol (2003) 1.24
An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol (2006) 1.24
Evidence for an association between KIBRA and late-onset Alzheimer's disease. Neurobiol Aging (2008) 1.24
DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. Ann Neurol (2004) 1.22
Lithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia. Neuropharmacology (2007) 1.19
Sexual differentiation of the bed nucleus of the stria terminalis in humans may extend into adulthood. J Neurosci (2002) 1.18
EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol (2004) 1.17
New actigraph for long-term tremor recording. Mov Disord (2006) 1.17
Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. J Neuroimmunol (2002) 1.16
Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions. J Neuropathol Exp Neurol (2009) 1.16
Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease. Neurobiol Aging (2006) 1.16
Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock". FASEB J (2006) 1.16
The human pineal gland and melatonin in aging and Alzheimer's disease. J Pineal Res (2005) 1.15
Akt activity in Alzheimer's disease and other neurodegenerative disorders. Neuroreport (2004) 1.15
Neuropathology of stress. Acta Neuropathol (2013) 1.14
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. J Pineal Res (2005) 1.14
Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One (2013) 1.12
Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis (2005) 1.12
Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders. Front Neuroendocrinol (2011) 1.10
Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp Gerontol (2003) 1.10
Hypothalamic thyroid hormone feedback in health and disease. Prog Brain Res (2006) 1.10
Circadian and age-related modulation of thermoreception and temperature regulation: mechanisms and functional implications. Ageing Res Rev (2002) 1.10
Sex hormone receptors are present in the human suprachiasmatic nucleus. Neuroendocrinology (2002) 1.09
Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain (2005) 1.08
Cells in human postmortem brain tissue slices remain alive for several weeks in culture. FASEB J (2002) 1.07
fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain (2006) 1.07
Non-pharmacological interventions in cognitively impaired and demented patients--a comparison with cholinesterase inhibitors. Rev Neurosci (2003) 1.07
Cutaneous warming promotes sleep onset. Am J Physiol Regul Integr Comp Physiol (2005) 1.06
Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology. Brain (2007) 1.06
Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res (2003) 1.05
Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. J Clin Endocrinol Metab (2005) 1.05
Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol Aging (2011) 1.05
Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav Brain Res (2007) 1.04
Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease. Neurobiol Aging (2005) 1.02
Early social stress in female guinea pigs induces a masculinization of adult behavior and corresponding changes in brain and neuroendocrine function. Behav Brain Res (2003) 1.01
Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol Aging (2006) 1.00
Skin temperature and sleep-onset latency: changes with age and insomnia. Physiol Behav (2006) 0.99
Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp Neurol (2002) 0.99
Reduction of NR1 and phosphorylated Ca2+/calmodulin-dependent protein kinase II levels in Alzheimer's disease. Neuroreport (2005) 0.98
Regional alteration of synapsin I in the hippocampal formation of Alzheimer's disease patients. Acta Neuropathol (2003) 0.98
GFAPdelta in radial glia and subventricular zone progenitors in the developing human cortex. Development (2010) 0.98
Comparison between informant-observed and actigraphic assessments of sleep-wake rhythm disturbances in demented residents of homes for the elderly. Am J Geriatr Psychiatry (2006) 0.98
Outbreak of scarlet fever associated with emm12 type group A Streptococcus in 2011 in Shanghai, China. Pediatr Infect Dis J (2012) 0.97
Alterations in the circadian rhythm of salivary melatonin begin during middle-age. J Pineal Res (2003) 0.97
Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS. J Neuroimmunol (2004) 0.97
Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells. Brain Pathol (2008) 0.97
Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment. Brain Res (2002) 0.96
Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus. Neuroreport (2002) 0.96
Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways. PLoS One (2009) 0.96
CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis. J Neuropathol Exp Neurol (2003) 0.96
β-arrestin1 regulates γ-secretase complex assembly and modulates amyloid-β pathology. Cell Res (2012) 0.95
The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. J Clin Endocrinol Metab (2005) 0.95
The more physical inactivity, the more agitation in dementia. Int Psychogeriatr (2010) 0.94
Diurnal rhythm of free estradiol during the menstrual cycle. Eur J Endocrinol (2003) 0.94
Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J Clin Endocrinol Metab (2003) 0.94
The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo. J Neuropathol Exp Neurol (2007) 0.94